ETR
65
2
AMAT
33
-13
HPE
44
-2
MU
28
-3
ALL
50
2
OI
42
-3
MAR
63
-5
FE
44
5
DAL
84
-3
HSY
31
-6
RL
69
-4
SNA
70
-5
PYPL
52
-2
GILD
47
-8
CNX
73
-3
LRCX
37
-9
VRSN
53
-5
ADBE
47
-9
FITB
60
-5
MRK
17
-5
ETR
65
2
AMAT
33
-13
HPE
44
-2
MU
28
-3
ALL
50
2
OI
42
-3
MAR
63
-5
FE
44
5
DAL
84
-3
HSY
31
-6
RL
69
-4
SNA
70
-5
PYPL
52
-2
GILD
47
-8
CNX
73
-3
LRCX
37
-9
VRSN
53
-5
ADBE
47
-9
FITB
60
-5
MRK
17
-5
Financhill
Back

Repligen Quote, Financials, Valuation and Earnings

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Sell
30

RGEN
Repligen

Last Price:
124.90
Seasonality Move:
7.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Repligen Price Quote

$124.90
+0.17 (+-12.31%)
(Updated: November 16, 2024 at 5:36 AM ET)

Repligen Key Stats

Sell
30
Repligen (RGEN) is a Sell
Day range:
$121.52 - $141.17
52-week range:
$113.50 - $211.13
Dividend yield:
0%
P/E ratio:
192.47
P/S ratio:
13.34
P/B ratio:
4.02%
Volume:
1.9M
Avg. volume:
629.5K
1-year change:
-20.01%
Market cap:
$8B
Revenue:
$638.8M
EPS:
$-0.04

How Much Does Repligen Make?

  • How Much Are Repligen's Sales Annually?
    RGEN Revenues are $638.8M
  • How Much Profit Does Repligen's Make A Year?
    RGEN net income is $41.6M

Is Repligen Growing As A Company?

  • What Is Repligen's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.03%
  • What Is Repligen's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.83%

Repligen Stock Price Performance

  • Did Repligen Stock Go Up Last Month?
    Repligen share price went down by -13.97% last month
  • Did RGEN's Share Price Rise Over The Last Year?
    RGEN share price fell by -20.01% over the past 1 year

What Is Repligen 52-Week High & Low?

  • What Is Repligen’s 52-Week High Share Price?
    Repligen has traded as high as $211.13 over the past 52 weeks
  • What Is Repligen’s 52-Week Low Share Price?
    Repligen has traded as low as $113.50 over the past 52 weeks

Repligen Price To Free Cash Flow

  • Is Repligen Stock Overvalued?
    Repligen is trading at a price to free cash flow ratio of 67.40
  • Is Repligen Stock Undervalued?
    Repligen EV to Free Cash Flow ratio is 65.03
  • What Is Repligen’s Price Earnings Growth Ratio?
    RGEN PEG ratio is 0.00
  • Is Repligen Trading At A Premium To Earnings?
    Repligen EV to EBIT ratio is 361.46

Is It Risky To Buy Repligen?

  • How Much Debt Does Repligen Have?
    Total long term debt quarterly is $587.2M
  • How Much Cash Does Repligen Have?
    Cash and short term investments quarterly total is $809.1M
  • What Is Repligen’s Book Value Per Share?
    Book value per share is 35.53

Is Repligen Cash Flow Positive?

  • What Is RGEN Cash Flow From Operations?
    Cash flow from operations (TTM) is $155.2M
  • What Is Repligen’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $252.6M
  • What Is Repligen’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$194.4M

Repligen Return On Invested Capital

  • Is Management Doing A Good Job?
    RGEN return on invested capital is -0.08%
  • What Is Repligen Return On Assets?
    ROA measures how assets are converting to revenues and is -0.07%
  • What Is RGEN Return On Equity?
    ROE is a measure of profitability and is -0.1%

Repligen Earnings Date & Stock Price

  • What Is Repligen's Stock Price Today?
    A single share of RGEN can be purchased today for 124.73
  • What Is Repligen’s Stock Symbol?
    Repligen trades on the nasdaq under the ticker symbol: RGEN
  • When Is Repligen’s Next Earnings Date?
    The next quarterly earnings date for Repligen is scheduled on February 21, 2025
  • When Is RGEN's next ex-dividend date?
    Repligen's next ex-dividend date is November 16, 2024
  • How To Buy Repligen Stock?
    You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Repligen Competitors

  • Who Are Repligen's Competitors?
    Below is a list of companies who compete with Repligen or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • QuidelOrtho Corp (QDEL)
    • Catheter Precision Inc (VTAK)
    • West Pharmaceutical Services Inc (WST)
    • Xtant Medical Holdings Inc (XTNT)

Repligen Dividend Yield

  • What Is RGEN Dividend Yield?
    Repligen’s dividend yield currently is 0%
  • What Is Repligen’s Payout Ratio?
    Repligen’s payout ratio is 0%
  • When Did Repligen Last Pay A Dividend?
    The latest dividend pay date is November 16, 2024
  • What Is Repligen’s Dividend Per Share?
    Repligen pays a dividend of $0.00 per share

Repligen Analyst Estimates

YoY Growth Past Surprise
EPS: -82.86% 29.38%
Revenue: -3.2% 1.03%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 192.25
Upside from Last Price: 54.13%

Major Shareholders

  • How many RGEN shares are owned by institutional investors?
    92.9M RGEN shares are owned by institutional investors
  • How many RGEN shares are owned by insiders?
    2.5M RGEN shares are owned by insiders